|
Alim-Louis Benabid is an emeritus professor, neurosurgeon and member of the Academy of Sciences in France, who has had a global impact in the development of deep brain stimulation (DBS) for Parkinson's disease and other movement disorders. He became emeritus professor of biophysics at the Joseph Fourier University in Grenoble in September 2007, and chairman of the board of the Edmond J. Safra Biomedical Research Center in 2009 at Clinatec, a multidisciplinary institute he co-founded in Grenoble that applies nanotechnologies to neurosciences. == Biography == Alim-Louis Benabid was born May 2, 1942 in Grenoble, France. The son of a doctor from Algeria, Benabid was quoted as saying he could not easily decide between studying physics or medicine. He received his medical degree in 1970 and a doctorate in physics in 1978, both from Joseph Fourier University in Grenoble.〔 He became a staff neurosurgeon at Joseph Fourier University in 1972, professor of experimental medicine in 1978, and professor of biophysics from 1983 – 2007. Benabid also had a fellowship in 1979 – 1980 in preclinical neuropharmacology in the laboratory of Floyd Bloom at the Salk Institute in La Jolla, California. From 1988 – 2007, he directed the preclinical neurosciences unit at the French biomedical and public health research institution INSERM, and from 1989 – 2007, served as head of the neurosurgery department at the University Hospital of Grenoble.〔 In other roles, Benabid coordinated the Claudio Munari Center for Surgery of Epilepsy and Movement Disorders at Hospital Niguarda in Milan, Italy from 1998 to 2007, and was a staff consultant at the Cleveland Clinic Foundation in Ohio from 2000 to 2003.〔 In 2007, Benabid joined the French Commissariat d’ Energie Atomique (CEA - France's nuclear and renewable energy commission) as a scientific adviser during the time a campus for public-private innovation was being created, the Grenoble Innovation for Advanced New Technologies (Giant) campus, which includes the Minatec research complex and the life-science cluster NanoBio.〔:fr:NanoBio〕 In 2009, he became chairman of the board of the Edmond J. Safra Biomedical Research Center at Clinatec, a translational biomedical technology organization he helped found within Minatec. Clinatec was jointly created by CEA-Leti (Laboratoire d'électronique des technologies de l'information—an applied micro- and nanotechnology subsidiary of CEA), Grenoble University Hospital, INSERM and Joseph Fourier University. In 2013, when awarding Benabid a $100,000 (Robert A. Pritzker Prize for Leadership in Parkinson's Research ) to fund continued research, the Michael J. Fox Foundation said in its award announcement that Benabid had published 523 scientific papers, achieving an H Index of 67, as well as given 18 honorary lectures, and received 23 medals and prizes.〔 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Alim-Louis Benabid」の詳細全文を読む スポンサード リンク
|